Global Bioinformatics Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Products and Services;
Bioinformatics Platform, Bioinformatics Services, and Knowledge Management ToolBy Sector;
Medical Bioinformatics, Animal Bioinformatics, Agriculture Bioinformatics, Academics, and OthersBy Application;
Microbial Genome, Gene Engineering, Drug Development, Personalized Medicine, Omics, and OthersBy End User;
Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Academic Research Institutes, and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Bioinformatics Market Overview
Bioinformatics Market (USD Million)
Bioinformatics Market was valued at USD 17,826.09 million in the year 2024. The size of this market is expected to increase to USD 49,685.34 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 15.8%.
Global Bioinformatics Market Growth, Share, Size, Trends and Forecast
*Market size in USD million
CAGR 15.8 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 15.8 % |
Market Size (2024) | USD 17,826.09 Million |
Market Size (2031) | USD 49,685.34 Million |
Market Concentration | Low |
Report Pages | 350 |
Major Players
- Illumina, Inc
- Life Technologies (Thermo Fischer Scientific, Inc.)
- Qiagen N.V.
- Agilent Technologies, Inc.
- PerkinElmer, Inc.
- Accelrys Inc.
- Geneva Bioinformatics SA
- Ontoforce
- Data4Cure
- Life Map Sciences (Biotime)
- ABM Inc
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Global Bioinformatics Market
Fragmented - Highly competitive market without dominant players
The bioinformatics market is playing an increasingly central role in driving innovation across life sciences by combining computational tools with biological data. With around 70% of biotechnology firms integrating bioinformatics into their workflows, the field is experiencing strong momentum. The ability to decode complex genomic data efficiently is transforming research methodologies and improving productivity across sectors.
Technological Advancements Fuel Growth
Modern bioinformatics platforms are embracing cloud-based solutions, AI, and machine learning to meet the growing demands for large-scale data analysis. Nearly 65% of vendors now offer cloud-integrated services, helping users scale operations and access insights faster. These advancements are enabling cost-efficient and flexible bioinformatics solutions.
Expanding Applications Across Sectors
The application of bioinformatics has broadened significantly into areas such as personalized medicine, crop improvement, and disease diagnostics. About 60% of research projects in clinical genetics and agriculture are now powered by bioinformatics platforms.
Rising Demand for Data-Driven Insights
There is a rising emphasis on tools for data mining, annotation, and visualization, with more than 55% of life sciences institutions increasing investments in bioinformatics infrastructure. These solutions support faster and more accurate decision-making, making data-driven insights a key competitive edge in modern research. transformative possibilities in data interpretation.
Bioinformatics Market Recent Developments
-
In June 2024, Washington University School of Medicine in St. Louis introduced the Center for Translational Bioinformatics, a joint effort by the McDonnell Genome Institute and the Institute for Informatics, Data Science & Biostatistics. This initiative supports precision medicine by merging patient records with genomic data for personalized healthcare.
-
In February 2024, Metabolon, Inc. launched a powerful bioinformatics platform at Biomarkers UK, enhancing metabolomics analysis in life sciences. Backed by 20+ years of experience and a proprietary library of over 5,400 metabolites, it includes tools like Pathway Analysis and Biomarker Lenses for deep data interpretation.
Bioinformatics Market Segment Analysis
Bioinformatics Segment Analysis
In this report, the Bioinformatics Market has been segmented by Products & Services, Sector, Application, End User, and Geography.
Bioinformatics Market, Segmentation by Products & Services
The Bioinformatics Market has been segmented by Products & Services into Bioinformatics Platform, Bioinformatics Services, and Knowledge Management Tool.
Bioinformatics Platform
The bioinformatics platform segment holds the largest market share at around 45%, driven by its critical role in data analysis, sequence alignment, and genomic mapping. These platforms provide integrated tools for researchers to interpret complex biological data and support personalized medicine and drug discovery.
Bioinformatics Services
Bioinformatics services account for approximately 35% of the market, offering solutions such as data management, consulting, and custom algorithm development. These services are increasingly outsourced by pharmaceutical companies and research institutions to optimize cost and expertise.
Knowledge Management Tool
The knowledge management tool segment contributes about 20% of the market. These tools facilitate data integration, information retrieval, and collaborative research, enabling scientists to manage and share biological knowledge bases more effectively across multidisciplinary projects.
Bioinformatics Market, Segmentation by Sector
The Bioinformatics Market has been segmented by Sector into Medical Bioinformatics, Animal Bioinformatics, Agriculture Bioinformatics, Academics, and Others.
Medical Bioinformatics
Medical bioinformatics dominates the market with a share of approximately 50%, driven by its critical applications in genomics, personalized medicine, and drug discovery. It plays a key role in clinical diagnostics, biomarker development, and improving healthcare outcomes through data-driven insights.
Animal Bioinformatics
Animal bioinformatics contributes around 15% to the global market and supports veterinary research, animal genetics, and livestock improvement programs. It is increasingly used in genomic selection and the study of zoonotic diseases and animal health management.
Agriculture Bioinformatics
Agriculture bioinformatics accounts for nearly 18% of the market, helping optimize crop breeding, enhance pest resistance, and boost agricultural productivity. It integrates genomics with plant science and plays a pivotal role in advancing sustainable farming practices.
Academics
The academic sector holds around 10% of the bioinformatics market, driven by increasing investments in research and education. Universities and research institutions use bioinformatics tools for training, data analysis, and contributing to biological databases and publications.
Others
The ‘Others’ segment, comprising about 7%, includes environmental bioinformatics, forensics, and industrial biotechnology. These emerging areas utilize bioinformatics for diverse applications like microbiome studies, bioremediation, and synthetic biology.
Bioinformatics Market, Segmentation by Application
The Bioinformatics Market has been segmented by Application into Microbial Genome, Gene Engineering, Drug Development, Personalized Medicine, Omics, and Others.
North America
North America leads the bioinformatics market with a share of approximately 40%, fueled by strong investments in genomics research, a robust biotech sector, and widespread adoption of next-generation sequencing technologies. The U.S. dominates the region, supported by major bioinformatics solution providers and academic collaborations.
Europe
Europe accounts for nearly 28% of the market, driven by increasing research funding, cross-border healthcare initiatives, and expanding applications in precision medicine. Countries like Germany, the UK, and France are key contributors, with growing focus on genomics data integration.
Asia Pacific
Asia Pacific is the fastest-growing region, holding around 22% of the market. Rapid advancements in bioinformatics infrastructure, rising government support, and the expansion of biotech startups in China, India, and Japan are accelerating regional demand for bioinformatics tools and platforms.
Middle East & Africa
The Middle East & Africa region represents about 5% of the market. Growth is driven by improving genomic research capabilities, emerging biotech hubs, and increasing awareness of bioinformatics applications in public health and agriculture.
Latin America
Latin America holds approximately 5% of the global market. Countries like Brazil and Mexico are investing in genomic medicine, bioinformatics education, and clinical research partnerships, supporting steady market growth in the region.
Bioinformatics Market, Segmentation by End User
The Bioinformatics Market has been segmented by End User into Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Academic Research Institutes, and Others.
Pharmaceutical and Biotechnology Companies
This segment dominates the bioinformatics market with over 50% share, driven by its role in drug discovery, genomic analysis, and biomarker identification. These companies rely heavily on bioinformatics tools to streamline R&D processes and accelerate precision medicine initiatives.
Clinical Laboratories
Clinical laboratories contribute around 20% of the market, using bioinformatics for genetic testing, molecular diagnostics, and data interpretation. These labs benefit from advanced platforms to support high-throughput sequencing and improve patient-specific treatment strategies.
Academic Research Institutes
Academic research institutes hold nearly 20% of the market, playing a key role in bioinformatics education and fundamental research. These institutions use computational tools for biological modeling, data analysis, and publishing insights across multiple domains.
Others
The 'Others' segment, comprising about 10%, includes agriculture research centers, contract research organizations, and government agencies. These users apply bioinformatics in diverse areas such as environmental monitoring, food safety, and public health genomics.
Bioinformatics Market, Segmentation by Geography
In this report, the Bioinformatics Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.
Regions and Countries Analyzed in this Report
Bioinformatics Market Share (%), by Geographical Region
Microbial Genome
The microbial genome segment accounts for approximately 15% of the market, supporting research in infectious diseases, antibiotic resistance, and industrial microbiology. Bioinformatics enables the annotation and comparison of microbial genomes, aiding in pathogen detection and vaccine development.
Gene Engineering
Gene engineering contributes about 18% of the bioinformatics market. It plays a vital role in gene editing, synthetic biology, and genome assembly. Bioinformatics tools accelerate the design of recombinant DNA and help identify genetic targets for therapy or research.
Drug Development
This segment holds nearly 25% of the market, leveraging bioinformatics for target identification, lead optimization, and clinical trial data analysis. Pharmaceutical companies rely on bioinformatics to reduce R&D timelines and enhance precision drug design.
Personalized Medicine
Personalized medicine represents about 20% of the global market, with bioinformatics at the core of genomic profiling and individualized treatment plans. It enables clinicians to match therapies with a patient’s genetic makeup for improved treatment outcomes.
Omics
The omics segment—including genomics, proteomics, metabolomics, and transcriptomics—holds nearly 15% of the market. Bioinformatics integrates multi-omics datasets to uncover biological pathways and support systems-level biomedical research.
Others
The 'Others' category, accounting for about 7%, includes applications in forensics, environmental biotechnology, and agricultural genomics. These emerging areas benefit from bioinformatics tools for data mining, pattern recognition, and genetic diversity analysis.
Bioinformatics Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Bioinformatics Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces—Drivers, Restraints, and Opportunities—affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
---|---|---|---|---|---|
Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers:
- Increasing Demand for Nucleic Acid And Protein Sequencing
- Increasing Initiatives from Governments And Private Organizations
- Accelerating Growth of Proteomics And Genomics
-
Increasing Research on Molecular Biology And Drug Discovery - The expanding focus on molecular biology and drug discovery is significantly driving the growth of the bioinformatics market. The integration of advanced computational tools in life sciences research is transforming how biological data is analyzed, enabling researchers to extract meaningful insights with greater speed and accuracy.
As pharmaceutical and biotechnology companies race to develop more effective and personalized treatments, the need for bioinformatics tools has grown rapidly. These tools facilitate the analysis of complex genomic and proteomic data, helping in the identification of new drug targets and the optimization of lead compounds. This capability shortens development timelines and enhances the success rate of therapeutic interventions.
Academic institutions and research labs increasingly rely on bioinformatics platforms to conduct high-throughput data analysis. With the explosion of biological datasets, especially in genomics, having efficient software and analytical pipelines is critical. The growing role of bioinformatics in accelerating discoveries and improving healthcare outcomes continues to boost its demand worldwide.
Restraints:
- Lack of Well-defined Standards And Common Data Formats for Integration of Data
- Data Complexity Concerns and Lack of User-Friendly Tools
-
Lack of skilled bioinformatics professionals - A major challenge to the bioinformatics market’s expansion is the shortage of qualified professionals who possess expertise in both biology and computational sciences. Bioinformatics is an interdisciplinary field, and the lack of individuals who can proficiently navigate both domains often creates a bottleneck in research and innovation.
This talent gap limits the adoption of advanced tools in many organizations, leading to underutilized software and slower data interpretation. As a result, research productivity is impacted, and institutions struggle to derive full value from their bioinformatics investments.
The rapid evolution of bioinformatics technologies requires continuous learning. However, many educational systems still lag in offering robust, interdisciplinary training programs that prepare students for real-world demands. To close this gap, there is a pressing need for improved training infrastructure and collaboration between academia and industry to produce a workforce skilled in handling next-gen data analysis tools.
Opportunities:
- Integration of Artificial Intelligence and Machine Learning
- Expansion of Collaborative Research Networks and Consortia
-
Rapid Growth of Next-Generation Sequencing (NGS) Technologies - The surging adoption of Next-Generation Sequencing (NGS) technologies has opened up vast opportunities for the bioinformatics market. NGS platforms generate massive amounts of genomic data that require sophisticated computational tools for storage, processing, and interpretation, making bioinformatics indispensable to modern research.
Applications of NGS span across areas like oncology, infectious disease diagnostics, and precision medicine. The increasing clinical relevance of genomic data has led to the growing deployment of bioinformatics pipelines that can automate and streamline data analysis, making these insights accessible even to non-specialists.
Furthermore, the decreasing cost of sequencing has made it viable for smaller labs and healthcare providers, expanding the user base for bioinformatics software and services. Cloud-based solutions are gaining traction, offering scalable, secure, and collaborative environments for global data sharing and analysis.This ongoing technological revolution continues to reshape biological and medical research. By enhancing the efficiency and accuracy of sequencing workflows, bioinformatics stands as a critical enabler in unlocking the potential of genomic science.
Bioinformatics Market Competitive Landscape Analysis
Key players in Bioinformatics Market include;
- Illumina, Inc
- Life Technologies (Thermo Fischer Scientific, Inc.)
- Qiagen N.V.
- Agilent Technologies, Inc.
- PerkinElmer, Inc.
- Accelrys Inc.
- Geneva Bioinformatics SA
- Ontoforce
- Data4Cure
- Life Map Sciences (Biotime)
- ABM Inc
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Market Share Analysis
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Products & Services
- Market Snapshot, By Sector
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Bioinformatics Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing Demand for Nucleic Acid And Protein Sequencing
- Increasing Initiatives from Governments And Private Organizations
- Accelerating Growth of Proteomics And Genomics
- Increasing Research on Molecular Biology And Drug Discovery
- Restraints
- Lack of Well-defined Standards And Common Data Formats for Integration of Data
- Data Complexity Concerns and Lack of User-Friendly Tools
- Lack of skilled bioinformatics professionals
- Opportunities
- Integration of Artificial Intelligence and Machine Learning
- Expansion of Collaborative Research Networks and Consortia
- Rapid Growth of Next-Generation Sequencing (NGS) Technologies
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Bioinformatics Market, By Products & Services, 2021 - 2031 (USD Million)
- Bioinformatics Platform
- Bioinformatics Services
- Knowledge Management Tool
- Bioinformatics Market, By Sector, 2021 - 2031 (USD Million)
- Medical Bioinformatics
- Animal Bioinformatics
- Agriculture Bioinformatics
- Academics
- Others
- Bioinformatics Market, By Application, 2021 - 2031 (USD Million)
- Microbial Genome
- Gene Engineering
- Drug Development
- Personalized Medicine
- Omics
- Others
- Bioinformatics Market, By End User, 2021 - 2031 (USD Million)
- Pharmaceutical and Biotechnology Companies
- Clinical Laboratories
- Academic Research Institutes
- Others
- Bioinformatics Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Bioinformatics Market, By Products & Services, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Illumina, Inc
- Life Technologies (Thermo Fischer Scientific, Inc.)
- Qiagen N.V.
- Agilent Technologies, Inc.
- PerkinElmer, Inc.
- Accelrys Inc.
- Geneva Bioinformatics SA
- Ontoforce
- Data4Cure
- Life Map Sciences (Biotime)
- ABM Inc.
- Company Profiles
- Analyst Views
- Future Outlook of the Market